Dynamin-Related Protein Drp1 Regulates Cardiac Excitation-Contraction-Bioenergetics Coupling

动力相关蛋白 Drp1 调节心脏兴奋-收缩-生物能耦合

基本信息

  • 批准号:
    10063889
  • 负责人:
  • 金额:
    $ 62.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-01-01 至 2023-11-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Mitochondrial dynamics, including fission, fusion, and movement, is a fundamental mechanism in regulating mitochondrial function. Dynamin-related protein 1 (Drp1) is the major GTP hydrolyzing protein that is responsible for fission. Studies have shown that Drp1 is abundantly expressed in adult cardiac myocytes. Paradoxically, compared to numerous cell types, adult cardiac myocytes exhibit very low frequency in mitochondrial fission. This dichotomy between the abundance of Drp1 and scarcity of mitochondrial fission has prompted us to investigate the non-canonical roles of Drp1 in cardiac muscle cells. We hypothesize that Drp1 is strategically accumulated in the mitochondria associated sarcoplasmic reticulum (SR) membrane (MAM). During excitation- contraction coupling, the localized high Ca2+ in the SR-mitochondria junctions further increases the translocation of nearby cytosolic Drp1 to mitochondria. Then, Drp1 is anchored firmly in the MAM by actin. The activation of Drp1 leads to enhanced mitochondrial respiration for ATP generation as such the heart can work most effectively and sustainably. However, excessive Drp1 activation leads to persistent mitochondrial transition pore opening and excessive reactive oxygen species (ROS) generation that causes cell injury and death. The following three specific aims are proposed to test this hypothesis. Aim 1: To determine whether and how Drp1 is preferentially localized in the SR-mitochondria junctions. Aim 2: To determine the molecular mechanisms by which Drp1 regulates excitation-contraction-bioenergetics coupling. Aim 3: To determine how chronic over activation of Drp1 leads to dysfunction in the stressed heart. We will employ multiple techniques, including biochemistry (from in vitro to in situ assays), molecular biology (gene knock in or knock out, overexpression, RNA interference), cell biology (confocal, fluorescence resonance energy transfer, super-resolution microscopy, electron microscopy), cardiac physiology (echocardiogram, NMR spectroscopy), and isoproterenol infusion mouse model of cardiac hypertrophy and failure, to obtain experimental results that will lead to mechanistic insights. Successful completion of the proposed aims will allow us to introduce a new paradigm that describes the regulation of excitation-contraction-bioenergetics-ROS nexus by Drp1 through localized Ca2+ activation and actin anchoring. This fundamental signaling mechanism will describe not only how a healthy heart can perform perpetually in face of enormous workload but also why the over activation of this unique process can lead to heart failure. Finally, this new knowledge will provide new insights in developing and discovering therapeutic agents targeting Drp1-mediated signaling pathways for treating heart failure.
项目总结/文摘

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Unsolved mysteries and controversies of mitochondria in the heart - A virtual special issue in JMCC.
心脏线粒体的未解之谜和争议 - JMCC 的虚拟特刊。
Unsolved mysteries and controversies of mitochondria in the heart- A Virtual Special Issue in JMCC: Part III.
心脏线粒体的未解之谜和争议 - JMCC 虚拟特刊:第三部分。
Elevated MCU Expression by CaMKIIδB Limits Pathological Cardiac Remodeling.
  • DOI:
    10.1161/circulationaha.121.055841
  • 发表时间:
    2022-04-05
  • 期刊:
  • 影响因子:
    37.8
  • 作者:
    Wang P;Xu S;Xu J;Xin Y;Lu Y;Zhang H;Zhou B;Xu H;Sheu SS;Tian R;Wang W
  • 通讯作者:
    Wang W
Unsolved mysteries and controversies of mitochondria in the heart - A virtual special issue in JMCC: Part II.
心脏线粒体的未解之谜和争议 - JMCC 的虚拟特刊:第二部分。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shey-Shing Sheu其他文献

Shey-Shing Sheu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shey-Shing Sheu', 18)}}的其他基金

Crosstalk Ca2+ Signaling between Ryanodine Receptors Type 1 and 2 in the Pathogenesis of Cardiac Hypertrophy and Heart Failure
心脏肥大和心力衰竭发病机制中 1 型和 2 型 Ryanodine 受体之间的串扰 Ca2 信号传导
  • 批准号:
    10660636
  • 财政年份:
    2023
  • 资助金额:
    $ 62.87万
  • 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
  • 批准号:
    8011076
  • 财政年份:
    2011
  • 资助金额:
    $ 62.87万
  • 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
  • 批准号:
    8267661
  • 财政年份:
    2011
  • 资助金额:
    $ 62.87万
  • 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
  • 批准号:
    8431698
  • 财政年份:
    2011
  • 资助金额:
    $ 62.87万
  • 项目类别:
ADP: A Master Regulator for Bioenergetics and Ca2+/ROS Signaling in Heart
ADP:心脏生物能学和 Ca2/ROS 信号传导的主调节器
  • 批准号:
    8311703
  • 财政年份:
    2011
  • 资助金额:
    $ 62.87万
  • 项目类别:
ADP: A Master Regulator for Bioenergetics and Ca2+/ROS Signaling in Heart
ADP:心脏生物能学和 Ca2/ROS 信号传导的主调节器
  • 批准号:
    8198299
  • 财政年份:
    2011
  • 资助金额:
    $ 62.87万
  • 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
  • 批准号:
    10521270
  • 财政年份:
    2010
  • 资助金额:
    $ 62.87万
  • 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
  • 批准号:
    10064104
  • 财政年份:
    2010
  • 资助金额:
    $ 62.87万
  • 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
  • 批准号:
    9887277
  • 财政年份:
    2010
  • 资助金额:
    $ 62.87万
  • 项目类别:
Ca2+ and ROS Crosstalk Signaling in Cardiac Mitochondria
心脏线粒体中的 Ca2 和 ROS 串扰信号传导
  • 批准号:
    8761519
  • 财政年份:
    2010
  • 资助金额:
    $ 62.87万
  • 项目类别:

相似海外基金

Structural basis for regulation of beta2 adrenergic receptor signaling by the dynamic post-translational modification S-palmitoylation
动态翻译后修饰S-棕榈酰化调节β2肾上腺素受体信号传导的结构基础
  • 批准号:
    10603466
  • 财政年份:
    2023
  • 资助金额:
    $ 62.87万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 62.87万
  • 项目类别:
    Discovery Grants Program - Individual
Glucocorticoid and Adrenergic Receptor Signaling at the Neuroimmune Interface
神经免疫界面的糖皮质激素和肾上腺素能受体信号传导
  • 批准号:
    RGPIN-2019-04706
  • 财政年份:
    2022
  • 资助金额:
    $ 62.87万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 62.87万
  • 项目类别:
    University Undergraduate Student Research Awards
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
  • 批准号:
    10629280
  • 财政年份:
    2022
  • 资助金额:
    $ 62.87万
  • 项目类别:
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
  • 批准号:
    10448574
  • 财政年份:
    2022
  • 资助金额:
    $ 62.87万
  • 项目类别:
Novel regulation of beta-adrenergic receptor function by phosphoinositide 3-kinase
磷酸肌醇 3-激酶对 β-肾上腺素能受体功能的新调节
  • 批准号:
    10591688
  • 财政年份:
    2022
  • 资助金额:
    $ 62.87万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 62.87万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 62.87万
  • 项目类别:
    University Undergraduate Student Research Awards
The molecular mechanism of the crosstalk between the beta-2 adrenergic receptor and chemokine receptors in lymphocytes
淋巴细胞β2肾上腺素受体与趋化因子受体串扰的分子机制
  • 批准号:
    22K07118
  • 财政年份:
    2022
  • 资助金额:
    $ 62.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了